Effect of Shock Wave Therapy on Myofascial Pain Syndrome in Adolescent Athletes
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Designed physical therapy program, Extracorporeal shock wave therapy (ESWT).
- Who it may be relevant to
- Registry conditions: Myofascial Pain Syndrome. Basic parameters: 14 years — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of the study is to determine the effect of extracorporeal shockwave therapy on pain, neck range of motion, and functional activity in adolescent athletes.
Detailed description
Myofascial pain syndrome is a syndrome characterized by pain and accompanying muscle spasms, referred pain patterns, stiffness, and restricted range of motion caused by trigger points on constricted fibers of muscles and/or fasciae. Myofascial pain syndrome is the most common reason for back pain, shoulder pain, tension-type headaches, and regional pains such as facial pain.
Myofascial trigger points (MTrPs) are understood as the morphological correlate of the myofascial pain syndrome (MPS), an acute or chronic muscular pain condition affecting a single muscle or a group of muscles. Active MTrPs are spontaneously painful, while latent MTrPs are only painful upon pressure. MTrP stimulation can also cause referred pain and the characteristic local twitch response.
The main goal of MPS treatment is to break down the vicious circle of "spasm - pain - spasm" and release trigger points. Various physical therapy modalities such as trigger point injection, stretching-spray technique or ultrasound (US), heat packs and transcutaneous electrical nerve stimulation (TENS), and extracorporeal shock wave therapy (ESWT), are used for the treatment of MPS. These modalities inactivate the trigger point with their thermal and mechanical effects.
Due to the lack of research area of extracorporeal shock wave therapy on myofascial pain syndrome on upper trapezius in adolescents' athletes, so the purpose of the study is to know impact of the extracorporeal shock wave therapy on myofascial pain syndrome on upper trapezius in adolescents' athletes.
Interventions
- Other Designed physical therapy program
Both groups will receive a designed physical therapy program, in the form of myofascial trigger points pressure release, stretching of the upper trapezius muscle, strengthening exercises, and infrared radiation for 4 weeks. - Other Extracorporeal shock wave therapy (ESWT)
Adolescents of the experimental group will receive Extracorporeal shock wave therapy with the following parameters; low-level energy radial extracorporeal shock wave by (STORZ MEDICAL Master Pulse MP200), each subject received 3 sessions per week for 4 weeks with 700 impulse/session 400 impulse was applied to tight band and 300 impulses will be applied surrounding the tight band, with frequency \[10HZ\], resulting in positive energy flux density \[EFD\] 0.056mJ/mm.
Primary outcome measures
- Assessment of pain level [Time frame: 4 weeks]
Secondary outcome measures (7)
- Assessment cervical flexion range of motion (ROM) [Time frame: 4 weeks]
- Assessment cervical extension range of motion (ROM) [Time frame: 4 weeks]
- Assessment cervical lateral flexion ROM to the right [Time frame: 4 weeks]
- Assessment cervical lateral flexion ROM to the left [Time frame: 4 weeks]
- Assessment cervical rotation ROM to the right [Time frame: 4 weeks]
- Assessment cervical rotation ROM to the left [Time frame: 4 weeks]
- Assessment of functional activity of neck [Time frame: 4 weeks]
Eligibility criteria
Inclusion criteria
- Age ranges from 14 to 18 years.
- All adolescents have regional pain complaint.
- Tenderness in cervical trigger points in the midpoint of the upper border of the trapezius muscle, from grade 2 to grade 4 according to the tenderness grading scheme (Hubbard, 1993) (Appendix II).
- Palpation of a trigger point elicits a stereotypic zone of referred pain specific to that muscle.
- Identification of a palpable taut band, as well as a palpable, and exquisitely tender spot along the length of that taut band.
- All adolescents are allowed to practice their regular sports activities.
Exclusion criteria
- Dermatological disorders.
- Having myofascial trigger points injection.
- Chronic pain in both sides of the body.
- History of findings of cervical injury whether orthopedic or soft tissue injury.
- Analgesic drugs or NSAIDs during the treatment period.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Ismailia Medical Complex — Ismailia
Identifiers
NCT: NCT06845475 · P.T.REC/012/005356